Avai Bio (AVAI) Other Non-Current Assets (2018 - 2023)

Avai Bio has disclosed Other Non-Current Assets across 6 years of filings, most recently posting $125.0 for Q1 2023.

• Other Non-Current Assets for Q1 2023 came in at $125.0, up 100.1% year-over-year; the trailing twelve-month figure through Mar 2023 was $125.0 (up 100.1% YoY), and the FY2023 annual result was $125.0, up 100.1% from the prior year.
• Other Non-Current Assets came in at $125.0 for Q1 2023 at Avai Bio, up from -$131394.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $8111.0 in Q2 2020 to a low of -$131394.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1938.0 (2020), against an average of -$12801.2.
• Across the five-year window, Other Non-Current Assets soared 14647.27% in 2020 and tumbled 6879.88% in 2022, its largest moves.
• Avai Bio's Other Non-Current Assets stood at $55.0 in 2019, then soared by 3547.27% to $2006.0 in 2020, then slipped by 3.39% to $1938.0 in 2021, then sank by 6879.88% to -$131394.0 in 2022, then soared by 100.1% to $125.0 in 2023.
• The last three Other Non-Current Assets figures came in at $125.0 (Q1 2023), -$131394.0 (Q1 2022), and $1938.0 (Q1 2021), per Business Quant data.